This company listing is no longer active
Wockhardt Bio Balance Sheet Health
Financial Health criteria checks 4/6
Wockhardt Bio has a total shareholder equity of $281.3M and total debt of $59.2M, which brings its debt-to-equity ratio to 21.1%. Its total assets and total liabilities are $631.9M and $350.6M respectively.
Key information
21.1%
Debt to equity ratio
US$59.23m
Debt
Interest coverage ratio | n/a |
Cash | US$38.50m |
Equity | US$281.28m |
Total liabilities | US$350.62m |
Total assets | US$631.90m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: WBIO's short term assets ($308.1M) do not cover its short term liabilities ($317.5M).
Long Term Liabilities: WBIO's short term assets ($308.1M) exceed its long term liabilities ($33.1M).
Debt to Equity History and Analysis
Debt Level: WBIO's net debt to equity ratio (7.4%) is considered satisfactory.
Reducing Debt: WBIO's debt to equity ratio has reduced from 103.8% to 21.1% over the past 5 years.
Debt Coverage: WBIO's debt is well covered by operating cash flow (111.6%).
Interest Coverage: Insufficient data to determine if WBIO's interest payments on its debt are well covered by EBIT.